🟢 CUPR soars 45.9% in pre-market after FDA 510(k) clearance and NASDAQ compliance

CUPR is trading at $5.75 (45.9% up) in pre-market. - The biomedical company announced it received 510(k) clearance from the FDA for MEDIFLY Maggots, a significant company-specific catalyst. - The stock continues a volatile stretch after recently regaining NASDAQ compliance on June 11, easing prior delisting concerns.